Literature DB >> 10188894

Fatigue in advanced cancer: a prospective controlled cross-sectional study.

P Stone1, J Hardy, K Broadley, A J Tookman, A Kurowska, R A'Hern.   

Abstract

Uncontrolled studies have reported that fatigue is a common symptom among patients with advanced cancer. It is also a frequent complaint among the general population. Simply asking cancer patients whether or not they feel fatigued does not distinguish between the 'background' level of this symptom in the community and any 'excess' arising as a result of illness. The aim of this study was to determine the prevalence of fatigue among palliative care inpatients in comparison with a control group of age and sex-matched volunteers without cancer. In addition, the correlates of fatigue were investigated. The prevalence of 'severe subjective fatigue' (defined as fatigue greater than that experienced by 95% of the control group) was found to be 75%. Patients were malnourished, had diminished muscle function and were suffering from a number of physical and mental symptoms. The severity of fatigue was unrelated to age, sex, diagnosis, presence or site of metastases, anaemia, dose of opioid or steroid, any of the haematological or biochemical indices (except urea), nutritional status, voluntary muscle function, or mood. A multivariate analysis found that fatigue severity was significantly associated with pain and dypnoea scores in the patients, and with the symptoms of anxiety and depression in the controls. The authors conclude that subjective fatigue is both prevalent and severe among patients with advanced cancer. The causes of this symptom remain obscure. Further work is required in order to determine if the associations reported between fatigue and pain and between fatigue and dyspnoea are causal or coincidental.

Entities:  

Mesh:

Year:  1999        PMID: 10188894      PMCID: PMC2362706          DOI: 10.1038/sj.bjc.6690236

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  31 in total

1.  Association between asthenia and nutritional status, lean body mass, anemia, psychological status, and tumor mass in patients with advanced breast cancer.

Authors:  E Bruera; C Brenneis; M Michaud; J Rafter; A Magnan; A Tennant; J Hanson; R N Macdonald
Journal:  J Pain Symptom Manage       Date:  1989-06       Impact factor: 3.612

2.  Lung cancer and dyspnea: the patient's perception.

Authors:  M L Brown; V Carrieri; M J Dodd
Journal:  Oncol Nurs Forum       Date:  1986 Sep-Oct       Impact factor: 2.172

3.  Triceps skin fold and upper arm muscle size norms for assessment of nutrition status.

Authors:  A R Frisancho
Journal:  Am J Clin Nutr       Date:  1974-10       Impact factor: 7.045

4.  Fatigue in the cancer patient: a conceptual approach to a clinical problem.

Authors:  J Aistars
Journal:  Oncol Nurs Forum       Date:  1987 Nov-Dec       Impact factor: 2.172

5.  Hospice care: the treatment of pain in advanced cancer.

Authors:  T D Walsh; C M Saunders
Journal:  Recent Results Cancer Res       Date:  1984

6.  Muscle electrophysiology in patients with advanced breast cancer.

Authors:  E Bruera; C Brenneis; M Michaud; P I Jackson; R N MacDonald
Journal:  J Natl Cancer Inst       Date:  1988-04-20       Impact factor: 13.506

7.  Fatigue, depression and quality of life in cancer patients: how are they related?

Authors:  M R Visser; E M Smets
Journal:  Support Care Cancer       Date:  1998-03       Impact factor: 3.603

8.  The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus.

Authors:  L B Krupp; N G LaRocca; J Muir-Nash; A D Steinberg
Journal:  Arch Neurol       Date:  1989-10

9.  A study of fatigue in systemic lupus erythematosus.

Authors:  L B Krupp; N G LaRocca; J Muir; A D Steinberg
Journal:  J Rheumatol       Date:  1990-11       Impact factor: 4.666

10.  Measuring symptoms in terminal cancer: are pain and dyspnoea controlled?

Authors:  I Higginson; M McCarthy
Journal:  J R Soc Med       Date:  1989-05       Impact factor: 18.000

View more
  49 in total

Review 1.  Lung cancer 7: management of lung cancer in elderly patients.

Authors:  R Booton; M Jones; N Thatcher
Journal:  Thorax       Date:  2003-08       Impact factor: 9.139

2.  Patterns of care in community-based oncology practices for anemia associated with myelosuppressive chemotherapy.

Authors:  Arash Naeim; Lyssa Friedman; Kimberly B Whitlock; David J Pasta; Eric P Elkin; Deborah P Lubeck; Hema N Viswanathan; John Glaspy
Journal:  J Oncol Pract       Date:  2009-09       Impact factor: 3.840

3.  Efficacy of an intervention for fatigue and sleep disturbance during cancer chemotherapy.

Authors:  Andrea Barsevick; Susan L Beck; William N Dudley; Bob Wong; Ann M Berger; Kyra Whitmer; Tracey Newhall; Susan Brown; Katie Stewart
Journal:  J Pain Symptom Manage       Date:  2010-06-18       Impact factor: 3.612

4.  The Flinders Fatigue Scale: preliminary psychometric properties and clinical sensitivity of a new scale for measuring daytime fatigue associated with insomnia.

Authors:  Michael Gradisar; Leon Lack; Hayley Richards; Jodie Harris; Julie Gallasch; Michelle Boundy; Anna Johnston
Journal:  J Clin Sleep Med       Date:  2007-12-15       Impact factor: 4.062

5.  The anticancer agent doxorubicin disrupts mitochondrial energy metabolism and redox balance in skeletal muscle.

Authors:  Laura A A Gilliam; Kelsey H Fisher-Wellman; Chien-Te Lin; Jill M Maples; Brook L Cathey; P Darrell Neufer
Journal:  Free Radic Biol Med       Date:  2013-09-07       Impact factor: 7.376

6.  [Modafinil for the treatment of cancer-related fatigue : an intervention study].

Authors:  S Wirz; J Nadstawek; K U Kühn; S Vater; U Junker; H C Wartenberg
Journal:  Schmerz       Date:  2010-12       Impact factor: 1.107

7.  Pain, depression, and fatigue in community-dwelling adults with and without a history of cancer.

Authors:  Cielito C Reyes-Gibby; Lu Ann Aday; Karen O Anderson; Tito R Mendoza; Charles S Cleeland
Journal:  J Pain Symptom Manage       Date:  2006-08       Impact factor: 3.612

8.  A randomised controlled trial to evaluate the efficacy of a 6-month dietary and physical activity intervention for patients receiving androgen deprivation therapy for prostate cancer.

Authors:  Roisin F O'Neill; Farhana Haseen; Liam J Murray; Joe M O'Sullivan; Marie M Cantwell
Journal:  J Cancer Surviv       Date:  2015-04-28       Impact factor: 4.442

9.  Doxorubicin acts through tumor necrosis factor receptor subtype 1 to cause dysfunction of murine skeletal muscle.

Authors:  Laura A A Gilliam; Leonardo F Ferreira; Joseph D Bruton; Jennifer S Moylan; Håkan Westerblad; Daret K St Clair; Michael B Reid
Journal:  J Appl Physiol (1985)       Date:  2009-09-24

10.  Fatigue in Brazilian cancer patients, caregivers, and nursing students: a psychometric validation study of the Piper Fatigue Scale-Revised.

Authors:  Dálete D C F Mota; Cibele A M Pimenta; Barbara F Piper
Journal:  Support Care Cancer       Date:  2008-11-06       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.